Table 1.
Baseline characteristics of all 427 patients
| Variables | n = 427 |
| Sex (male/female) | 362/65 |
| Age (yr) | 51.1 ± 10.4 |
| Surgical indications | |
| HCC | 391 |
| ICC | 31 |
| HCC-ICC1 | 5 |
| Tumor size (cm) | 6.2 ± 4.0 |
| WBC (× 109/L) | 5.5 ± 1.8 |
| PLT (× 109/L) | 160.5 ± 66.4 |
| PT (s) | 12.2 ± 4.8 |
| Total bilirubin (μmol/L) | 14.6 ± 5.8 |
| Albumin (g/L) | 42.0 ± 4.0 |
| Prealbumin (mg/dL) | 217.6 ± 61.0 |
| ALT (IU/L) | 47.4 ± 43.7 |
| Hepatitis virus background | |
| HBV | 362 |
| HCV | 4 |
| HBV-HCV2 | 3 |
| None | 58 |
| Liver cirrhosis | |
| Yes | 234 |
| No | 193 |
| Ascites | |
| Little | 48 |
| No | 378 |
| Esophageal varices | |
| Present | 60 |
| Absent | 367 |
| Types of liver resection | |
| Minor ≤ 3 liver segments | 358 |
| Major ≥ 4 liver segments | 69 |
| Inflow blood occlusion time (min) | 15.8 ± 8.0 |
| Blood loss (mL) | 200 (50, 5500) |
| Blood transfusion (yes/no) | 43/384 |
1
Concurrence of HCC and ICC;
2
Concurrence of HBV and HCV. HCC: Hepatocellular carcinoma; ICC: Intrahepatic cholangiocarcinoma; WBC: White blood cell; PLT: Platelet; PT: Prothrombin time; ALT: Alanine aminotransferase; HBV: Hepatitis B virus; HCV: Hepatitis C virus.